FDA: ‘No evidence’ 2nd Paxlovid course stops recurring symptoms May 5, 2022 Auto Bot News 0 An FDA official said there is currently no evidence a longer course of Pfizer’s COVID-19 antiviral treatment would benefit patients experiencing a rebound in symptoms.